Mélanie Brignone

424 total citations
21 papers, 323 citations indexed

About

Mélanie Brignone is a scholar working on Pharmacology, Experimental and Cognitive Psychology and Biological Psychiatry. According to data from OpenAlex, Mélanie Brignone has authored 21 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 6 papers in Experimental and Cognitive Psychology and 5 papers in Biological Psychiatry. Recurrent topics in Mélanie Brignone's work include Treatment of Major Depression (13 papers), Tryptophan and brain disorders (5 papers) and Mental Health Research Topics (5 papers). Mélanie Brignone is often cited by papers focused on Treatment of Major Depression (13 papers), Tryptophan and brain disorders (5 papers) and Mental Health Research Topics (5 papers). Mélanie Brignone collaborates with scholars based in France, Denmark and United States. Mélanie Brignone's co-authors include Bernhard T. Baune, Klaus Groes Larsen, Natalya Danchenko, Benoît Rive, Ioana Florea, Henrik Loft, Paula L. Jacobsen, C. François, Pierre‐Michel Llorca and David V. Sheehan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Thoracic Oncology and BMC Psychiatry.

In The Last Decade

Mélanie Brignone

21 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mélanie Brignone France	11	208	118	61	59	43	21	323
Sebastian Ebert Denmark	4	107 0.5×	55 0.5×	71 1.2×	55 0.9×	37 0.9×	5	291
Signe Hellmuth Denmark	4	107 0.5×	55 0.5×	70 1.1×	48 0.8×	39 0.9×	6	316
Michaela Strobelberger United States	7	178 0.9×	84 0.7×	120 2.0×	54 0.9×	35 0.8×	13	388
Alessia Gatti Italy	4	147 0.7×	84 0.7×	116 1.9×	15 0.3×	30 0.7×	5	285
S. Troy France	8	155 0.7×	104 0.9×	169 2.8×	37 0.6×	24 0.6×	15	313
Sophie Robert United States	11	111 0.5×	37 0.3×	60 1.0×	22 0.4×	34 0.8×	23	406
Edmund C. Settle United States	10	253 1.2×	113 1.0×	289 4.7×	44 0.7×	22 0.5×	15	598
Shubhra Mace United Kingdom	9	125 0.6×	49 0.4×	277 4.5×	42 0.7×	33 0.8×	14	467
C. Spadone France	7	108 0.5×	91 0.8×	92 1.5×	26 0.4×	28 0.7×	21	269
Michaela‐Elena Friedrich Austria	8	42 0.2×	45 0.4×	74 1.2×	33 0.6×	30 0.7×	12	304

Countries citing papers authored by Mélanie Brignone

Since Specialization

Citations

This map shows the geographic impact of Mélanie Brignone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mélanie Brignone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mélanie Brignone more than expected).

Fields of papers citing papers by Mélanie Brignone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mélanie Brignone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mélanie Brignone. The network helps show where Mélanie Brignone may publish in the future.

Co-authorship network of co-authors of Mélanie Brignone

This figure shows the co-authorship network connecting the top 25 collaborators of Mélanie Brignone. A scholar is included among the top collaborators of Mélanie Brignone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mélanie Brignone. Mélanie Brignone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Augustin, Matthias & Mélanie Brignone. (2025). Optimization of Basic Emollient Therapy for the Management of Xerosis Cutis. International Journal of Dermatology. 64(S1). 53–57. 1 indexed citations

Atsou, Kokuvi, Larry Ereshefsky, Mélanie Brignone, et al.. (2020). Cost-effectiveness of vortioxetine compared with levomilnacipran and vilazodone in patients with major depressive disorder switching from an initial antidepressant. Expert Review of Pharmacoeconomics & Outcomes Research. 21(1). 29–42. 2 indexed citations

Ezzedine, Khaled, et al.. (2020). Use of complete clearance for assessing treatment efficacy for 5-fluorouracil interventions in actinic keratoses: how baseline lesion count can impact this outcome. SHILAP Revista de lepidopterología. 8(1). 1829884–1829884. 10 indexed citations

François, C., et al.. (2019). From investigational product to active reference: evolution of oral sumatriptan efficacy versus placebo for the treatment of acute migraine episodes and potential impact in comparative analyses. SHILAP Revista de lepidopterología. 7(1). 1603538–1603538. 1 indexed citations

Haro, Josep María, François-Xavier Lamy, Bengt Jönsson, et al.. (2018). Characteristics of patients with depression initiating or switching antidepressant treatment: baseline analyses of the PERFORM cohort study. BMC Psychiatry. 18(1). 80–80. 6 indexed citations

Baune, Bernhard T., Mélanie Brignone, & Klaus Groes Larsen. (2017). A Network Meta-Analysis Comparing Effects of Various Antidepressant Classes on the Digit Symbol Substitution Test (DSST) as a Measure of Cognitive Dysfunction in Patients with Major Depressive Disorder. The International Journal of Neuropsychopharmacology. 21(2). 97–107. 100 indexed citations

Thase, Michael E., Natalya Danchenko, Mélanie Brignone, et al.. (2017). Comparative evaluation of vortioxetine as a switch therapy in patients with major depressive disorder. European Neuropsychopharmacology. 27(8). 773–781. 21 indexed citations

Florea, Ioana, Henrik Loft, Natalya Danchenko, et al.. (2017). The effect of vortioxetine on overall patient functioning in patients with major depressive disorder. Brain and Behavior. 7(3). e00622–e00622. 33 indexed citations

Soini, Erkki, Taru Hallinen, Mélanie Brignone, et al.. (2016). Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland. Expert Review of Pharmacoeconomics & Outcomes Research. 17(3). 293–302. 18 indexed citations

10.

Brignone, Mélanie, et al.. (2015). Efficacy and tolerability of switching therapy to vortioxetine versus other antidepressants in patients with major depressive disorder. Current Medical Research and Opinion. 32(2). 351–366. 22 indexed citations

11.

Florea, Ioana, Natalya Danchenko, Mélanie Brignone, et al.. (2015). The Effect of Vortioxetine on Health-related Quality of Life in Patients With Major Depressive Disorder. Clinical Therapeutics. 37(10). 2309–2323.e6. 24 indexed citations

12.

Brignone, Mélanie, et al.. (2015). Cost-effectiveness of vortioxetine versus venlafaxine (extended release) in the treatment of major depressive disorder in South Korea. Expert Review of Pharmacoeconomics & Outcomes Research. 16(5). 629–638. 12 indexed citations

13.

Llorca, Pierre‐Michel, Christophe Lançon, Mélanie Brignone, et al.. (2015). Can we well assess the relative efficacy and tolerability of a new drug versus others at the time of marketing authorization using mixed treatment comparisons? A detailed illustration with escitalopram. Journal of Market Access & Health Policy. 3(1). 26776–26776. 1 indexed citations

14.

Annemans, Lieven, et al.. (2014). Cost-Effectiveness Analysis of Pharmaceutical Treatment Options in the First-Line Management of Major Depressive Disorder in Belgium. PharmacoEconomics. 32(5). 479–493. 15 indexed citations

15.

Llorca, Pierre‐Michel, Christophe Lançon, Mélanie Brignone, et al.. (2014). Relative efficacy and tolerability of vortioxetine versus selected antidepressants by indirect comparisons of similar clinical studies. Current Medical Research and Opinion. 30(12). 2589–2606. 24 indexed citations

16.

Nuijten, Mark, Mélanie Brignone, Florence Marteau, Johan A. den Boer, & Erik Hoencamp. (2012). Cost-Effectiveness of Escitalopram in Major Depressive Disorder in the Dutch Health Care Setting. Clinical Therapeutics. 34(6). 1364–1378. 9 indexed citations

17.

Tilleul, P., Mélanie Brignone, Martine Billard, et al.. (2012). A multicenter prospective observational study of the conformity of temozolomide prescriptions in France. Pharmacoepidemiology and Drug Safety. 21(8). 828–834. 3 indexed citations

18.

Bernard, Mélisande, et al.. (2010). Perception of alopecia by patients requiring chemotherapy for non-small-cell lung cancer: A willingness to pay study. Lung Cancer. 72(1). 114–118. 15 indexed citations

19.

David, Jean, et al.. (2010). [Management and follow-up of patients treated with antiretroviral prophylaxis: an evaluation of professional practices].. PubMed. 22(4). 393–403. 2 indexed citations

20.

Brignone, Mélanie, Anne Aupérin, V. Grassi, et al.. (2007). C8-05: Critical review of meta-analyses of randomized controlled trials (RCTs) studying lung cancer treatment: assessment of their quality. Journal of Thoracic Oncology. 2(8). S384–S384. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact